ALX Oncology

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALX Oncology and other ETFs, options, and stocks.

About ALXO

ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic syndromes, acute myeloid leukemia, and a range of solid tumor indications.

CEO

Jason Lettmann

CEOJason Lettmann

Employees

Employees80

Headquarters

South San Francisco, California

HeadquartersSouth San Francisco, California

Founded

2015

Founded2015

Employees

Employees80

ALXO Key Statistics

Market cap

23.37M

Market cap23.37M

Price-Earnings ratio

-0.18

Price-Earnings ratio-0.18

Dividend yield

—

Dividend yield—

Average volume

506.26K

Average volume506.26K

High today

$0.4934

High today$0.4934

Low today

$0.4282

Low today$0.4282

Open price

$0.4357

Open price$0.4357

Volume

328.13K

Volume328.13K

52 Week high

$15.35

52 Week high$15.35

52 Week low

$0.41

52 Week low$0.41

Analyst ratings

83%

of 6 ratings

Buy

83.3%

Hold

16.7%

Sell

People also own

Based on the portfolios of people who own ALXO. This list is generated using Robinhood data, and it’s not a recommendation.